TGF-alpha as a candidate tumor antigen for renal cell carcinomas

Cancer Immunology, Immunotherapy

Volumn 58, Issue 8, 2009, Pages 1207-1218

  Pelletier, Sandy ^a,b   Tanguay, Simon ^c   Lee, Stephen ^d   Gunaratnam, Lakshman ^d   Arbour, Nathalie ^a   Lapointe, Réjean ^a,b  

^a NOTRE DAME HOSPITAL   (Canada)

^b Institut du Cancer de Montreal   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cancer immunotherapy; Clear cell renal cell carcinoma; Polyfunctional antigen specific T lymphocytes; Transforming growth factor (TGF) ; Tumor antigen

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CANCER IMMUNOTHERAPY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

EID: 67349208136     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0630-2     Document Type: Article

References (51)

1. SH Landis T Murray S Bolden PA Wingo 1999 Cancer statistics, 1999 CA Can J Clin 49 8 31 (Pubitemid 29094959)
2. AJ Schrader Z Varga A Hegele S Pfoertner P Olbert R Hofmann 2006 Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches J Can Res Clin Oncol 132 137 149 (Pubitemid 43015774)
3. JC Yang RM Sherry SM Steinberg SL Topalian DJ Schwartzentruber P Hwu CA Seipp L Rogers-Freezer KE Morton DE White DJ Liewehr MJ Merino SA Rosenberg 2003 Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer J Clin Oncol 21 3127 3132 (Pubitemid 46606294)
4. DF McDermott MM Regan JI Clark LE Flaherty GR Weiss TF Logan JM Kirkwood MS Gordon JA Sosman MS Ernstoff CPG Tretter WJ Urba JW Smith KA Margolin JW Mier JA Gollob JP Dutcher MB Atkins 2005 Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma J Clin Oncol 23 133 141 (Pubitemid 41702632)
5. E Oosterwijk FMJ Debruyne JA Schalken 1995 The use of monoclonal-antibody G250 in the therapy of renal-cell carcinoma Semin Oncol 22 34 41
6. K Grabmaier JLM Vissers MCA de Weijert JC Oosterwijk-Wakka A Van Bokhoven RH Brakenhoff E Noessner PA Mulders G Merkx CG Figdor GJ Adema E Oosterwijk 2000 Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250 Int J Cancer 85 865 870 (Pubitemid 30131479)
7. J Fischer G Palmedo R von Knobloch P Bugert T Prayer-Galetti F Pagano G Kovacs 1998 Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours Oncogene 17 733 739 (Pubitemid 28412494)
8. Y Hedberg E Davoodi G Roos B Ljungberg G Landberg 1999 Cyclin-D1 expression in human renal-cell carcinoma Int J Cancer 84 268 272 (Pubitemid 29256753)
9. N Oehlrich G Devitt M Linnebacher Y Schwitalle S Grosskinski S Stevanovic M Zoller 2005 Generation of RAGE-1 and MAGE-9 peptide-specific cytotoxic T-lymphocyte lines for transfer in patients with renal cell carcinoma Int J Cancer 117 256 264 (Pubitemid 41377446)
10. de Paulsen N, Brychzy A, Fournier MC, Klausner RD, Gnarra JR, Pause A, Lee S (2001) Role of transforming growth factor-alpha in von Hippel-Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci USA 98(4:)1387-1392 (Pubitemid 32165508)
11. L Gunaratnam M Morley A Franovic N de Paulsen K Mekhail DAE Parolin E Nakamura IAJ Lorimer S Lee 2003 Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL-/- renal cell carcinoma cells J Biol Chem 278 44966 44974 (Pubitemid 37377256)
12. M Ivan K Kondo HF Yang W Kim J Valiando M Ohh A Salic JM Asara WS Lane WG Kaelin 2001 HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O-2 sensing Science 292 464 468 (Pubitemid 32335941)
13. M Krieg R Haas H Brauch T Acker I Flamme KH Plate 2000 Up-regulation of hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function Oncogene 19 5435 5443 (Pubitemid 32000910)
14. ME Bonicalzi I Groulx N de Paulsen S Lee 2001 Role of exon 2-encoded beta-domain of the von Hippel-Lindau tumor suppressor protein J Biol Chem 276 1407 1416 (Pubitemid 32096572)
15. SC Clifford ME Cockman AC Smallwood DR Mole ER Woodward PH Maxwell PJ Ratcliffe ER Maher 2001 Contrasting effects on HIF-1 alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease Hum Mol Gen 10 1029 1038 (Pubitemid 32447780)
16. MS Wiesener PM Munchenhagen I Berger NV Morgan J Roigas A Schwiertz JS Jurgensen G Gruber PH Maxwell SA Loning U Frei ER Maher HJ Grone KU Eckardt 2001 Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1 alpha in clear cell renal carcinomas Can Res 61 5215 5222 (Pubitemid 32681556)
17. B Escudier A Pluzanska P Koralewski A Ravaud S Bracarda C Szczylik C Chevreau M Filipek B Melichar E Bajetta V Gorbunova JO Bay I Bodrogi A Jagiello-Gruszfeld N Moore 2007 Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Lancet 370 2103 2111 (Pubitemid 350296300)
18. B Escudier T Eisen WM Stadler C Szczylik S Oudard M Siebels S Negrier C Chevreau E Solska AA Desai F Rolland T Demkow TE Hutson M Gore S Freeman B Schwartz M Shan R Simantov RM Bukowski 2007 Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125 134 (Pubitemid 46089673)
19. RJ Motzer TE Hutson P Tomczak MD Michaelson RM Bukowski O Rixe S Oudard S Negrier C Szczylik ST Kim I Chen PW Bycott CM Baum RA Figlin 2007 Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 115 124 (Pubitemid 46089672)
20. SJ Mandriota KJ Turner DR Davies PG Murray NV Morgan HM Sowter CC Wykoff ER Maher AL Harris PJ Ratcliffe PH Maxwell 2002 HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron Cancer Cell 1 459 468 (Pubitemid 41039126)
21. O Iliopoulos A Kibel S Gray WG Kaelin 1995 Tumor suppression by the human von Hippel-Lindau gene-product Nat Med 1 822 826
22. R Lapointe A Bellemare-Pelletier F Housseau J Thibodeau P Hwu 2003 CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells Can Res 63 2836 2843 (Pubitemid 36667155)
23. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene Proc Natl Acad Sci USA 91 9461 9465 (Pubitemid 24297934)
24. MA Forget S Turcotte D Beauseigle J Godin-Ethier S Pelletier J Martin S Tanguay R Lapointe 2007 The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types Br J Cancer 96 646 653 (Pubitemid 46303529)
25. MW Pfaffl 2001 A new mathematical model for relative quantification in real-time RT-PCR Nuc Acids Res 29 e45
26. MW Pfaffl GW Horgan L Dempfle 2002 Relative expression software tool (REST (c)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nuc Acids Res 30 e36
27. S Topalian L Muul D Solomon SA Rosenberg 1987 Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials J Immunol Methods 102 127 141 (Pubitemid 17151559)
28. LG Gomella ER Sargent TP Wade P Anglard WM Linehan A Kasid 1989 Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma Cancer Res 49 6972 6975 (Pubitemid 20016577)
29. PE Petrides S Bock J Bovens R Hofmann G Jakse 1990 Modulation of pro-epidermal growth-factor, pro-transforming growth factor-alpha and epidermal growth-factor receptor gene-expression in human renal carcinomas Cancer Res 50 3934 3939 (Pubitemid 20225609)
30. JH Mydlo J Michaeli C Cordoncardo AS Goldenberg WDW Heston WR Fair 1989 Expression of transforming growth factor-alpha and epidermal growth-factor receptor messenger-rna in neoplastic and nonneoplastic human-kidney tissue Cancer Res 49 3407 3411 (Pubitemid 19162159)
31. DJ Lager DD Slagel PL Palechek 1994 The expression of epidermal growth-factor receptor and transforming growth-factor-alpha in renal-cell carcinoma Modern Pathol 7 544 548
32. DL Uhlman P Nguyen JC Manivel G Zhang K Hagen E Fraley D Aeppli GA Niehans 1995 Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis Clin Cancer Res 1 913 920
33. K Smith L Gunaratnam M Morley A Franovic K Mekhail S Lee 2005 Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer Cancer Res 65 5221 5230 (Pubitemid 40827332)
34. JE Kudlow AW Leung MS Kobrin AJ Paterson SL Asa 1989 Transforming growth factor-alpha in the mammalian brain. Immunohistochemical detection in neurons and characterization of its mRNA J Biol Chem 264 3880 3883 (Pubitemid 19072272)
35. DS Liscia G Merlo F Ciardiello N Kim GH Smith R Callahan DS Salomon 1990 Transforming growth factor-alpha messenger-RNA localization in the developing adult-rat and human mammary-gland by in situ hybridization Dev Biol 140 123 131
36. C Liu A Woo MS Tsao 1990 Expression of transforming growth factor-alpha in primary human colon and lung carcinomas Br J Cancer 62 425 429 (Pubitemid 20292840)
37. DM Thomas MM Nasim WJ Gullick MR Alison 1992 Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract Gut 33 628 631
38. AB Gottlieb CK Chang DN Posnett B Fanelli JP Tam 1988 Detection of transforming growth factor-alpha in normal, malignant, and hyperproliferative human keratinocytes J Exp Med 167 670 675 (Pubitemid 18073665)
39. RJ Coffey Jr R Derynck JN Wilcox TS Bringman AS Goustin HL Moses MR Pittelkow 1987 Production and auto-induction of transforming growth factor-alpha in human keratinocytes Nature 328 817 820 (Pubitemid 17125960)
40. DK Madtes EW Raines KS Sakariassen RK Assoian MB Sporn GI Bell R Ross 1988 Induction of transforming growth factor-alpha in activated human alveolar macrophages Cell 53 285 293 (Pubitemid 18139065)
41. MR Betts MC Nason SM West SC De Rosa SA Migueles J Abraham MM Lederman JM Benito PA Goepfert M Connors M Roederer RA Koup 2006 HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells Blood 107 4781 4789 (Pubitemid 43882629)
42. SA Younes B Yassine-Diab AR Dumont MR Boulassel Z Grossman JP Routy RP Sekaly 2003 HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity J Exp Med 198 1909 1922 (Pubitemid 38032123)
43. C Iyasere JC Tilton AJ Johnson S Younes B Yassine-Diab RP Sekaly WW Kwok SA Migueles AC Laborico WL Shupert CW Hallahan RT Davey Jr M Dybul S Vogel J Metcalf M Connors 2003 Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2 J Virol 77 10900 10909 (Pubitemid 37204283)
44. SC Zimmerli A Harari C Cellerai F Vallelian PA Bart G Pantaleo 2005 HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells Proc Natl Acad Sci USA 102 7239 7244 (Pubitemid 40696363)
45. B Seliger T Cabrera F Garrido S Ferrone 2002 HLA class I antigen abnormalities and immune escape by malignant cells Semin Cancer Biol 12 3 13 (Pubitemid 34087893)
46. HT Khong NP Restifo 2002 Natural selection of tumor variants in the generation of "tumor escape" phenotypes Nat Immunol 3 11 999 1005 (Pubitemid 35363649)
47. MJ Smyth DI Godfrey JA Trapani 2001 A fresh look at tumor immunosurveillance and immunotherapy Nat Immunol 2 293 299 (Pubitemid 33706339)
48. M Tateishi T Ishida T Mitsudomi S Kaneko K Sugimachi 1990 Immunohistochemical evidence of autocrine growth-factors in adenocarcinoma of the human lung Cancer Res 50 7077 7080 (Pubitemid 20361116)
49. C Liu MS Tsao 1993 Invitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas Am J Pathol 142 1155 1162 (Pubitemid 24060591)
50. CM Barton PA Hall CM Hughes WJ Gullick NR Lemoine 1991 Transforming growth factor-alpha and epidermal growth-factor in human pancreatic-cancer J Pathol 163 111 116
51. S Tanaka K Imanishi M Yoshihara K Haruma K Sumii G Kajiyama S Akamatsu 1991 Immunoreactive transforming growth factor-alpha is commonly present in colorectal neoplasia Am J Pathol 139 123 129